1.
Full Text
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)
Autophagy, ISSN 1554-8627, 01/2016, Volume 12, Issue 1, pp. 1 - 222
stress | chaperone-mediated autophagy | vacuole | autolysosome | macroautophagy | flux | autophagosome | LC3 | lysosome | phagophore | Phagophore | Lysosome | Autolysosome | Flux | Autophagosome | Vacuole | Chaperonemediated autophagy | Macroautophagy | Stress | ACTIVATED PROTEIN-KINASE | ENDOPLASMIC-RETICULUM STRESS | STARVATION-INDUCED AUTOPHAGY | GLUCAGON-INDUCED AUTOPHAGY | CELL BIOLOGY | PROGRAMMED CELL-DEATH | LIFE-SPAN EXTENSION | BETAINE HOMOCYSTEINE METHYLTRANSFERASE | VACUOLAR MEMBRANE DYNAMICS | NF-KAPPA-B | Autophagy - physiology | Biological Assay - methods | Animals | Biological Assay - standards | Computer Simulation | Humans | Life Sciences | Medical and Health Sciences | Medicin och hälsovetenskap
Journal Article
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, ISSN 0735-1097, 05/2010, Volume 55, Issue 20, pp. 2201 - 2209
Objectives The aim of this randomized, single-blind, controlled trial was to assess N-acetylcysteine effects on contrast-induced nephropathy and reperfusion...
free radicals | magnetic resonance imaging | CARDIAC & CARDIOVASCULAR SYSTEMS | SIZE | infarction | RENAL-FUNCTION | PREVENTION | RISK | ABCIXIMAB | ANGIOGRAPHY | AREA | contrast media | nephropathy | TRANSMURALITY | reperfusion | PRIMARY ANGIOPLASTY | Single-Blind Method | Prospective Studies | Humans | Middle Aged | Free Radical Scavengers - administration & dosage | Logistic Models | Male | Treatment Outcome | Acute Kidney Injury - prevention & control | Angioplasty, Balloon, Coronary | Magnetic Resonance Imaging | Myocardial Infarction - therapy | Contrast Media - adverse effects | Creatinine - blood | Female | Acute Kidney Injury - chemically induced | Aged | Oxidative Stress - drug effects | Acetylcysteine - administration & dosage | Myocardial Reperfusion Injury - prevention & control | Oxidative stress | Enzymes | Heart attacks | Nuclear magnetic resonance--NMR | Hydration | Rodents | Mortality | Clinical medicine | Kinases | Multivariate analysis | Veins & arteries
free radicals | magnetic resonance imaging | CARDIAC & CARDIOVASCULAR SYSTEMS | SIZE | infarction | RENAL-FUNCTION | PREVENTION | RISK | ABCIXIMAB | ANGIOGRAPHY | AREA | contrast media | nephropathy | TRANSMURALITY | reperfusion | PRIMARY ANGIOPLASTY | Single-Blind Method | Prospective Studies | Humans | Middle Aged | Free Radical Scavengers - administration & dosage | Logistic Models | Male | Treatment Outcome | Acute Kidney Injury - prevention & control | Angioplasty, Balloon, Coronary | Magnetic Resonance Imaging | Myocardial Infarction - therapy | Contrast Media - adverse effects | Creatinine - blood | Female | Acute Kidney Injury - chemically induced | Aged | Oxidative Stress - drug effects | Acetylcysteine - administration & dosage | Myocardial Reperfusion Injury - prevention & control | Oxidative stress | Enzymes | Heart attacks | Nuclear magnetic resonance--NMR | Hydration | Rodents | Mortality | Clinical medicine | Kinases | Multivariate analysis | Veins & arteries
Journal Article
PLoS Medicine, ISSN 1549-1277, 03/2016, Volume 13, Issue 3, p. e1001967
Ebola virus disease (EVD) is a highly lethal condition for which no specific treatment has proven efficacy. In September 2014, while the Ebola outbreak was at...
VIRAL LOAD | MEDICINE, GENERAL & INTERNAL | HEMORRHAGIC-FEVER | PATIENT | INFECTION | T-705 FAVIPIRAVIR | OUTCOMES | CONVALESCENT PLASMA | OUTBREAK | SEVERE SEPSIS | FEATURES | Antiviral Agents - therapeutic use | Guinea | Humans | Child, Preschool | Therapies, Investigational | Infant | Male | RNA, Viral - blood | Treatment Outcome | Amides - therapeutic use | Pyrazines - therapeutic use | Ebolavirus - genetics | Reverse Transcriptase Polymerase Chain Reaction | Viral Load | Feasibility Studies | Young Adult | Hemorrhagic Fever, Ebola - diagnosis | Adolescent | Adult | Female | Historically Controlled Study | Child | Hemorrhagic Fever, Ebola - drug therapy | Antiviral agents | Ebola virus infections | Drug therapy | Patient outcomes | Care and treatment | RNA | Mortality | Genomics | Clinical trials | Hostages | Biosafety | Oral medication | Ethical aspects | Non-governmental organizations | Ebola virus | Virus diseases | Analysis | Health aspects | Studies | Epidemics | Life Sciences | Social Anthropology and ethnology | Humanities and Social Sciences
VIRAL LOAD | MEDICINE, GENERAL & INTERNAL | HEMORRHAGIC-FEVER | PATIENT | INFECTION | T-705 FAVIPIRAVIR | OUTCOMES | CONVALESCENT PLASMA | OUTBREAK | SEVERE SEPSIS | FEATURES | Antiviral Agents - therapeutic use | Guinea | Humans | Child, Preschool | Therapies, Investigational | Infant | Male | RNA, Viral - blood | Treatment Outcome | Amides - therapeutic use | Pyrazines - therapeutic use | Ebolavirus - genetics | Reverse Transcriptase Polymerase Chain Reaction | Viral Load | Feasibility Studies | Young Adult | Hemorrhagic Fever, Ebola - diagnosis | Adolescent | Adult | Female | Historically Controlled Study | Child | Hemorrhagic Fever, Ebola - drug therapy | Antiviral agents | Ebola virus infections | Drug therapy | Patient outcomes | Care and treatment | RNA | Mortality | Genomics | Clinical trials | Hostages | Biosafety | Oral medication | Ethical aspects | Non-governmental organizations | Ebola virus | Virus diseases | Analysis | Health aspects | Studies | Epidemics | Life Sciences | Social Anthropology and ethnology | Humanities and Social Sciences
Journal Article
Nature, ISSN 0028-0836, 08/2015, Volume 524, Issue 7563, pp. 97 - 101
West Africa is currently witnessing the most extensive Ebola virus (EBOV) outbreak so far recorded(1-3). Until now, there have been 27,013 reported cases and...
MODEL | VP24 | INFERENCE | MULTIDISCIPLINARY SCIENCES | Sierra Leone - epidemiology | Humans | Molecular Sequence Data | Hemorrhagic Fever, Ebola - transmission | Male | Disease Outbreaks - statistics & numerical data | Phylogeny | Ebolavirus - genetics | Guinea - epidemiology | Hemorrhagic Fever, Ebola - epidemiology | Mali - epidemiology | Ebolavirus - isolation & purification | Hemorrhagic Fever, Ebola - virology | Amino Acid Substitution - genetics | Female | Spatio-Temporal Analysis | High-Throughput Nucleotide Sequencing | Liberia - epidemiology | Evolution, Molecular | Ebola virus | Ebola virus infections | Distribution | Proteins | Epidemics | Phylogenetics | Evolution | Infections | Genomes | Epidemiology
MODEL | VP24 | INFERENCE | MULTIDISCIPLINARY SCIENCES | Sierra Leone - epidemiology | Humans | Molecular Sequence Data | Hemorrhagic Fever, Ebola - transmission | Male | Disease Outbreaks - statistics & numerical data | Phylogeny | Ebolavirus - genetics | Guinea - epidemiology | Hemorrhagic Fever, Ebola - epidemiology | Mali - epidemiology | Ebolavirus - isolation & purification | Hemorrhagic Fever, Ebola - virology | Amino Acid Substitution - genetics | Female | Spatio-Temporal Analysis | High-Throughput Nucleotide Sequencing | Liberia - epidemiology | Evolution, Molecular | Ebola virus | Ebola virus infections | Distribution | Proteins | Epidemics | Phylogenetics | Evolution | Infections | Genomes | Epidemiology
Journal Article